Biotech

SPDR(R) S&P(R) Biotech ETF

$89.32

+8.9% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
(R) S&P(R) Biotech ETF XBI
Fund Size
$7.72 Billion
Dividend
0.0%
Fees
0.35%
Biotechnology ETF IBB
Fund Size
$8.24 Billion
Dividend
0.3%
Fees
0.44%
ARK Genomic Revolution ETF ARKG
Fund Size
$1.66 Billion
Dividend
0.0%
Fees
0.75%
NYSE Arca Biotechnology Index Fund FBT
Fund Size
$1.29 Billion
Dividend
0.0%
Fees
-
Biotechnology & Genome ETF PBE
Fund Size
$311 Million
Dividend
0.1%
Fees
-
View 7 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $15.1 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.21 %
Beta Indicates the relationship between the price performance of a share and the market. 1.0196
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 233.65
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -37.87
Profitable Companies 20
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 428.34
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 10.29
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 5.25
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -20.53
Enterprise Value to Revenue Enterprise value divided by revenue 220.15
Total Debt to Enterprise Value Total debt divided by enterprise value 0.09
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.5577
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -4706.21%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -20.20%
Return on Assets Indicates a company's profitability in relation to its total assets. -24.05%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -28.21%

Industries

Healthcare 90.5%
Other 4.0%
N/A 5.6%

Market cap

Micro Cap 5%
Small Cap 24%
Mid Cap 47%
Large Cap 24%
Mega Cap 1%

126 Investments

P/E-Ratio
Total Investment
Weight
State Street Global Advisors logo

MDY

State Street Global Advisors

P/E-Ratio
0.0
Total Investment
$558 Million
Weight
8.0%
Cytokinetics Inc logo

CYTK - Manufacturing

Cytokinetics Inc

P/E-Ratio
-11.9
Total Investment
$196 Million
Weight
2.8%
Karuna Therapeutics Inc logo

KRTX - Manufacturing

Karuna Therapeutics Inc

P/E-Ratio
0.0
Total Investment
$123 Million
Weight
1.8%
ACADIA Pharmaceuticals Inc logo

ACAD - Manufacturing

ACADIA Pharmaceuticals Inc

P/E-Ratio
-1434.8
Total Investment
$120 Million
Weight
1.7%
Biohaven Ltd logo

BHVN - Manufacturing

Biohaven Ltd

P/E-Ratio
0.0
Total Investment
$104 Million
Weight
1.5%
Amicus Therapeutics Inc logo

FOLD - Manufacturing

Amicus Therapeutics Inc

P/E-Ratio
-19.1
Total Investment
$101 Million
Weight
1.4%
Blueprint Medicines Corp logo

BPMC - Manufacturing

Blueprint Medicines Corp

P/E-Ratio
-23.2
Total Investment
$99.9 Million
Weight
1.4%
Arrowhead Pharmaceuticals Inc logo

ARWR - Manufacturing

Arrowhead Pharmaceuticals Inc

P/E-Ratio
-6.6
Total Investment
$99.7 Million
Weight
1.4%
Bridgebio Pharma Inc logo

BBIO - Manufacturing

Bridgebio Pharma Inc

P/E-Ratio
-10.8
Total Investment
$99.4 Million
Weight
1.4%
Moderna Inc logo

MRNA - Manufacturing

Moderna Inc

P/E-Ratio
-8.5
Total Investment
$99.2 Million
Weight
1.4%
Ultragenyx Pharmaceutical Inc logo

RARE - Manufacturing

Ultragenyx Pharmaceutical Inc

P/E-Ratio
-5.8
Total Investment
$94.7 Million
Weight
1.4%
Akero Therapeutics Inc logo

AKRO - Manufacturing

Akero Therapeutics Inc

P/E-Ratio
0.0
Total Investment
$94.1 Million
Weight
1.3%
REVOLUTION Medicines Inc logo

RVMD - Manufacturing

REVOLUTION Medicines Inc

P/E-Ratio
-13.3
Total Investment
$93.4 Million
Weight
1.3%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
28.3
Total Investment
$93.1 Million
Weight
1.3%
Krystal Biotech Inc logo

KRYS - Manufacturing

Krystal Biotech Inc

P/E-Ratio
0.0
Total Investment
$93 Million
Weight
1.3%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
17.1
Total Investment
$92 Million
Weight
1.3%
Exact Sciences Corp logo

EXAS - Professional, Scientific, and Technical Services

Exact Sciences Corp

P/E-Ratio
-39.9
Total Investment
$91.6 Million
Weight
1.3%
Roivant Sciences Ltd logo

ROIV

Roivant Sciences Ltd

P/E-Ratio
2.0
Total Investment
$91.5 Million
Weight
1.3%
Iovance Biotherapeutics Inc logo

IOVA - Manufacturing

Iovance Biotherapeutics Inc

P/E-Ratio
0.0
Total Investment
$90.5 Million
Weight
1.3%
Alnylam Pharmaceuticals Inc logo

ALNY - Manufacturing

Alnylam Pharmaceuticals Inc

P/E-Ratio
-57.6
Total Investment
$90.2 Million
Weight
1.3%
Neurocrine Biosciences Inc logo

NBIX - Manufacturing

Neurocrine Biosciences Inc

P/E-Ratio
38.6
Total Investment
$90 Million
Weight
1.3%
Madrigal Pharmaceuticals Inc logo

MDGL - Manufacturing

Madrigal Pharmaceuticals Inc

P/E-Ratio
0.0
Total Investment
$89 Million
Weight
1.3%
Recursion Pharmaceuticals Inc logo

RXRX - Professional, Scientific, and Technical Services

Recursion Pharmaceuticals Inc

P/E-Ratio
-6.1
Total Investment
$89 Million
Weight
1.3%
Insmed Inc logo

INSM - Manufacturing

Insmed Inc

P/E-Ratio
-5.0
Total Investment
$88.8 Million
Weight
1.3%
Vaxcyte Inc logo

PCVX - Manufacturing

Vaxcyte Inc

P/E-Ratio
0.0
Total Investment
$88.8 Million
Weight
1.3%